CellSeed's Regenerative medicine technology
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
- IR Summary of Non-Consolidated Financial Results for the Nine Months Ended September 30, 2022 (J-GAAP)
- IR Fiscal 2022 First-Half Earnings Results Presentation
- IR Summary of Non-Consolidated Financial Results for the Six Months Ended June 30, 2022 (J-GAAP)
- Others Company Brochure – Fiscal Year 2021, “With You CellSeed Vol. 14”
- Others Bridge Report the fiscal year 2021